Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
13621
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease
Published 2020“…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
-
13622
-
13623
-
13624
Figure 5
Published 2009“…The decreased heart rate shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0006867#pone-0006867-g005" target="_blank">Figure 5A</a> was predominantly due to an increase in diastolic intervals (<0.001), not an increase in systolic intervals (0.09).…”
-
13625
Localisation and quantification of VGLUT3 immunoreactivity within the hippocampus of WT and dystrophin-deficient mice, reacted and imaged under identical conditions.
Published 2014“…<p>(A) shows the pattern of VGLUT3 immunoreactivity within the hippocampus of WT mouse tissue. …”
-
13626
Data_Sheet_1_Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence.pdf
Published 2022“…The patient was prescribed nirmatrelvir/ritonavir to treat SARS-CoV-2 persistence at 3.5 months post-acute infection and observed a reduction in PASC symptoms 3 weeks after completing antiviral treatment. …”
-
13627
-
13628
-
13629
-
13630
A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients
Published 2019“…The mean period of wig use was 12.5 months. However, a few patients were still using wigs 5 years after completing chemotherapy.…”
-
13631
Figure 5
Published 2024“…<p dir="ltr">Figure 5: Cytotoxicity of Peptoid TM5 in three-dimensional models of the human lung A549 cells were treated with peptoid for 3 hours, then analyzed by MTT assay. …”
-
13632
-
13633
-
13634
-
13635
-
13636
-
13637
-
13638
-
13639
-
13640